Chin Hai Teo

Chin Hai Teo

Auto-generated profile, based on publicly available information

Chin Hai Teo

Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Social Science & Medicine
Verified
Journal Article
Open access
CTChin Hai Teo
Chin Hai Teo
CNChirk Jenn Ng
Chirk Jenn Ng
ABAndrew Booth
Andrew Booth
AWAlan White
Alan White
Men have poorer health status and are less likely to attend health screening compared to women. This systematic review presents current evidence on the barriers and facilitators to engaging men in health screening. We included qualitative, quantitative and mixed-method studies identified through five electronic databases, contact with experts and reference mining. Two researchers selected and appraised the studies independently. Data extraction and synthesis were conducted using the 'best fit' framework synthesis method. 53 qualitative, 44 quantitative and 6 mixed-method studies were included. Factors influencing health screening uptake in men can be categorized into five domains: individual, social, health system, healthcare professional and screening procedure. The most commonly reported barriers are fear of getting the disease and low risk perception; for facilitators, they are perceived risk and benefits of screening. Male-dominant barriers include heterosexual -self-presentation, avoidance of femininity and lack of time. The partner's role is the most common male-dominant facilitator to screening. This systematic review provides a comprehensive overview of barriers and facilitators to health screening in men including the male-dominant factors. The findings are particularly useful for clinicians, researchers and policy makers who are developing interventions and policies to increase screening uptake in men.

6 July 2015 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
CNChirk Jenn Ng
Chirk Jenn Ng
PLP. S. M. Lai
P. S. M. Lai
PLPing Yein Lee
Ping Yein Lee
SAS. A. Azmi
S. A. Azmi
CTC. H. Teo
C. H. Teo
Aim To identify the barriers and facilitators to start insulin in patients with type 2 diabetes. Method This was a systematic review. We conducted a systematic search using PubMed, EMBASE, CINAHL and Web of Science (up to 5 June 2014) for original English articles using the terms ‘type 2 diabetes’, ‘insulin’, and free texts: ‘barrier’ or ‘facilitate’ and ‘initiate’. Two pairs of reviewers independently assessed and extracted the data. Study quality was assessed with Qualsyst. Results A total of 9740 references were identified: 41 full‐text articles were assessed for eligibility. Twenty‐five articles (15 qualitative, 10 quantitative) were included in the review. Good inter‐rater reliability was observed for the Qualsyst score (weighted kappa 0.7). Three main themes identified were as follows: patient‐related, healthcare professional and system factors. The main patient‐related barriers were fear of pain and injection (n = 18), concerns about side effects of insulin (n = 12), perception that insulin indicated end stage of diabetes (n = 11), inconvenience (n = 10), difficulty in insulin administration (n = 7), punishment (n = 7) and stigma and discrimination (n = 7). Healthcare professionals’ barriers were as follows: poor knowledge and skills (n = 9), physician inertia (n = 5) and language barriers (n = 4). System barriers included lack of time (n = 5). The most common facilitators were understanding the benefits of insulin (n = 7), not being afraid of injections (n = 5), and patient education and information (n = 5). Conclusion Major barriers to insulin initiation persist despite availability of newer and safer insulin. Healthcare professionals should explore and address these barriers. Targeted interventions should be developed to overcome these barriers.

3 September 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
CNChirk Jenn Ng
Chirk Jenn Ng
CTChin Hai Teo
Chin Hai Teo
NANurdiana Abdullah
Nurdiana Abdullah
WTWei Phin Tan
Wei Phin Tan
HTHui Meng Tan
Hui Meng Tan
Cancer incidence and mortality varies across region, sex and country’s economic status. While most studies focused on global trends, this study aimed to describe and analyse cancer incidence and mortality in Asia, focusing on cancer site, sex, region and income status. Age-standardised incidence and mortality rates of cancer were extracted from the GLOBOCAN 2012 database. Cancer mortality to incidence ratios (MIRs) were calculated to represent cancer survival. The data were analysed based on the four regions in Asia and income. Cancer incidence rate is lower in Asia compared to the West but for MIR, it is the reverse. In Asia, the most common cancers in men are lung, stomach, liver, colorectal and oesophageal cancers while the most common cancers in women are breast, lung, cervical, colorectal and stomach cancers. The MIRs are the highest in lung, liver and stomach cancers and the lowest in colorectal, breast and prostate cancers. Eastern and Western Asia have a higher incidence of cancer compared to South-Eastern and South-Central Asia but this pattern is the reverse for MIR. Cancer incidence rate increases with country income particularly in colorectal and breast cancers but the pattern is the opposite for MIR. This study confirms that there is a wide variation in cancer incidence and mortality across Asia. This study is the first step towards documenting and explaining the changing cancer pattern in Asia in comparison to the rest of the world.

21 November 2022 in BMC Medical Ethics
Verified
Journal Article
Open access
PDF file
Mohd Yusmiaidil Putera Mohd YusofMohd Yusmiaidil Putera Mohd Yusof
Mohd Yusmiaidil Putera Mohd Yusof
CTChin Hai Teo
Chin Hai Teo
CNChirk Jenn Ng
Chirk Jenn Ng
Background: The research shows a growing trend in using an electronic platform to supplement or replace traditional paper-based informed consent processes. Instead of the traditionally written informed consent document, electronic informed consent (eConsent) may be used to assess the research subject’s comprehension of the information presented. By doing so, respect for persons as one of the research ethical principles can be upheld. Furthermore, these electronic methods may reduce potential airborne infection exposures, particularly during the pandemic, thereby adhering to the beneficence and nonmaleficence principle. This scoping review aims to identify the ethics related criteria that have been included in electronic informed consent processes and to synthesize and map these criteria to research ethics principles, in order to identify the gaps, if any, in current electronic informed consent processes.Methods: The search was performed based on internet search and three main databases: PubMed, SCOPUS and EBSCO. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation guideline was used to report this work.Results: Of 34 studies that met the inclusion criteria, 242 essential original constructs were collated, and 7 concepts were derived. Digital content showed the highest percentage of collated original constructs (27%, n = 65) followed by accessibility (24%, n = 56), comprehension engagement (18%, n = 43), autonomy (14%, n = 34), confidentiality (11%, n = 25), language (5%, n = 13), and parental consent (1%, n = 2). Twenty-five new items were synthesized for eConsent criteria which may provide guidance for ethical review of research involving eConsent.Conclusion: The current study adds significant value to the corpus of knowledge in research ethics by providing ethical criteria on electronic informed consent based on evidence-based data. The new synthesized items in the criteria can be readily used as an initial guide by the IRB/REC members during a review process on electronic informed consent and useful to the future preparation of a checklist.

16 October 2021 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
TNTze Chang Ng
Tze Chang Ng
CTChin Hai Teo
Chin Hai Teo
JTJia Yong Toh
Jia Yong Toh
ADAdam G. Dunn
Adam G. Dunn
CNChirk Jenn Ng
Chirk Jenn Ng
CLChee Sun Liew
Chee Sun Liew
Objective: Delays in seeking healthcare for dengue are associated with poor health outcomes. Despite this, the factors influencing such delays remain unclear, rendering interventions to improve healthcare seeking for dengue ineffective. This systematic review aimed to synthesise the factors influencing healthcare seeking of patients with dengue and form a comprehensive framework.Methods: This review included both qualitative and quantitative studies. Studies were obtained by searching five databases, contacting field experts and performing backward reference searches. The best‐fit meta‐synthesis approach was used during data synthesis, where extracted data were fitted into the social‐ecological model. Sub‐analyses were conducted to identify the commonly reported factors and their level of statistical significance.Results: Twenty studies were selected for meta‐synthesis. Eighteen factors influencing healthcare seeking in dengue were identified and categorised under four domains: individual (11 factors), interpersonal (one factor), organisational (four factors) and community (two factors). The most reported factors were knowledge of dengue, access to healthcare, quality of health service and resource availability. Overall, more barriers to dengue health seeking than facilitators were found. History of dengue infection and having knowledge of dengue were found to be ambiguous as they both facilitated and hindered dengue healthcare seeking. Contrary to common belief, women were less likely to seek help for dengue than men.Conclusions: The factors affecting dengue healthcare‐seeking behaviour are diverse, can be ambiguous and are found across multiple social‐ecological levels. Understanding these complexities is essential for the development of effective interventions to improve dengue healthcare‐seeking behaviour.

26 February 2021 in JMIR Medical Informatics
Verified
Journal Article
Open access
HLHooi Min Lim
Hooi Min Lim
CTChin Hai Teo
Chin Hai Teo
CNChirk Jenn Ng
Chirk Jenn Ng
TCThiam Kian Chiew
Thiam Kian Chiew
WNWei Leik Ng
Wei Leik Ng
CCChee Seng Chan
Chee Seng Chan
Background: During the COVID-19 pandemic, there was an urgent need to develop an automated COVID-19 symptom monitoring system to reduce the burden on the health care system and to provide better self-monitoring at home. Objective: This paper aimed to describe the development process of the COVID-19 Symptom Monitoring System (CoSMoS), which consists of a self-monitoring, algorithm-based Telegram bot and a teleconsultation system. We describe all the essential steps from the clinical perspective and our technical approach in designing, developing, and integrating the system into clinical practice during the COVID-19 pandemic as well as lessons learned from this development process. Methods: CoSMoS was developed in three phases: (1) requirement formation to identify clinical problems and to draft the clinical algorithm, (2) development testing iteration using the agile software development method, and (3) integration into clinical practice to design an effective clinical workflow using repeated simulations and role-playing. Results: We completed the development of CoSMoS in 19 days. In Phase 1 (ie, requirement formation), we identified three main functions: a daily automated reminder system for patients to self-check their symptoms, a safe patient risk assessment to guide patients in clinical decision making, and an active telemonitoring system with real-time phone consultations. The system architecture of CoSMoS involved five components: Telegram instant messaging, a clinician dashboard, system administration (ie, back end), a database, and development and operations infrastructure. The integration of CoSMoS into clinical practice involved the consideration of COVID-19 infectivity and patient safety. Conclusions: This study demonstrated that developing a COVID-19 symptom monitoring system within a short time during a pandemic is feasible using the agile development method. Time factors and communication between the technical and clinical teams were the main challenges in the development process. The development process and lessons learned from this study can guide the future development of digital monitoring systems during the next pandemic, especially in developing countries.